Single dose microparticles polio vaccine success in rats


Researchers in the US have developed a type of microparticle, that can deliver and release vaccines at set times, to create a single dose ‘self-boosting” vaccine’.


Vaccination programmes for diseases such as Covid-19 or polio, require multiple shots to protect the recipient, but poor patient attendance on vaccination programmes is a significant problem, particularly for people living in remote areas, leaving them vulnerable to life-threatening diseases.


To tackle this, researchers from the Koch Institute for Integrative Cancer Research at MIT, in Boston, Massachusetts, have developed microparticles which resemble tiny coffee cups sealed with a lid, that contain the vaccine.


These microparticles are made of a biodegradable polymer which can be designed to degrade after a specified period of time, allowing the researchers to control when the vaccine is released.


In its recent study, featured in PNAS, the research team successfully used a single dose microparticles vaccine against polio in rats.


“Such a single injection approach has the potential to not only improve patient compliance, but also increase cellular and humoral immune responses to the vaccine,” said senior author Robert Langer.


End

Recent Posts

See All